ArticleCancer cell international2019

miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway.

Tian-Liang Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.